Integra LifeSciences Holdings vs. ResMed Inc.
ResMed Inc. (RMD) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| IART | RMD | |
|---|---|---|
| Market Cap | $1.25 billion | $31.90 billion |
| Revenue (TTM) | $1.65 billion | — |
| Net Income (TTM) | $-7,242,000 | — |
RMD leads on 1 of 1 size & scale factors.
Valuation
| IART | RMD | |
|---|---|---|
| Price / Book | 1.20 | — |
| Price / Sales | 0.76 | — |
IART and RMD split the valuation factors evenly.
Profitability
| IART | RMD | |
|---|---|---|
| Net Margin | -0.44% | — |
| Return on Equity | -0.69% | — |
IART and RMD split the profitability factors evenly.
Dividend
| IART | RMD | |
|---|---|---|
| Dividend Yield | — | 1.19% |
IART and RMD split the dividend factors evenly.
Risk & Sentiment
| IART | RMD | |
|---|---|---|
| Short Interest | 6.92% | 4.04% |
RMD leads on 1 of 1 risk & sentiment factors.
Dig deeper: IART overview, IART financials, RMD overview, RMD financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.